39 results
Page 2 of 2
8-K
EX-1.1
l780u p5nritt33n2
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
424B5
jtt7aedz61sc17gxs
19 Sep 18
Prospectus supplement for primary offering
4:27pm
424B5
mp4okl9d68
7 Jun 18
Prospectus supplement for primary offering
5:13pm
8-K
EX-1.1
b2ek02m 9sllkcpvy7
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
424B5
jf6jg0uc32ot670z7z8
6 Jun 18
Prospectus supplement for primary offering
4:11pm
424B4
3noge
8 Apr 16
Prospectus supplement with pricing info
12:00am
10-K
jq4n2hsil jsr4tv
8 Mar 16
Annual report
12:00am
CORRESP
6eql wl229jhudw
19 Sep 14
Correspondence with SEC
12:00am
CORRESP
486sn gs1
16 Sep 14
Correspondence with SEC
12:00am